Mission
Okklo’s mission is to improve the quality of life of patients by means of developing new cyclodextrin-based therapeutic approaches.
Vision
Our vision is to be the leading company developing therapeutic cyclodextrins.
In this role, Okklo, will be an valuable and respected partner for any other party (investigator, SME, larger pharmaceutical company, patient organization or other) looking to develop therapeutic cyclodextrins with an highly experienced team.